Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients

Baricitinib is an oral Janus kinase (JAK)1/JAK2 inhibitor approved for the treatment of rheumatoid arthritis (RA) that was independently predicted, using artificial intelligence (AI) algorithms, to be useful for COVID‐19 infection via proposed anti‐cytokine effects and as an inhibitor of host cell v...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:EMBO Mol Med
Main Authors: Stebbing, Justin, Krishnan, Venkatesh, de Bono, Stephanie, Ottaviani, Silvia, Casalini, Giacomo, Richardson, Peter J, Monteil, Vanessa, Lauschke, Volker M, Mirazimi, Ali, Youhanna, Sonia, Tan, Yee‐Joo, Baldanti, Fausto, Sarasini, Antonella, Terres, Jorge A Ross, Nickoloff, Brian J, Higgs, Richard E, Rocha, Guilherme, Byers, Nicole L, Schlichting, Douglas E, Nirula, Ajay, Cardoso, Anabela, Corbellino, Mario
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300657/
https://ncbi.nlm.nih.gov/pubmed/32473600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012697
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker